Commit To Purchase BioCryst Pharmaceuticals At $2, Earn 18.6% Annualized Using Options
April 22, 2016 at 11:37 AM EDT
Investors considering a purchase of BioCryst Pharmaceuticals, Inc. (BCRX) shares, but cautious about paying the going market price of $3.35/share, might benefit from considering selling puts among the alternative strategies at their disposal..